Litcius/Paper detail

Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma

Benjamin P. Sharpe, Liliya Nazlamova, Carmen Tse, David A. Johnston, Jaya Thomas, Rhianna R R Blyth, Oliver Pickering, Ben Grace, Jack Harrington, Rushda Rajak, Matthew Rose‐Zerilli, Zoë S. Walters, Tim Underwood

2024Cell Reports Methods13 citationsDOIOpen Access PDF

Abstract

The tumor microenvironment (TME) comprises all non-tumor elements of cancer and strongly influences disease progression and phenotype. To understand tumor biology and accurately test new therapeutic strategies, representative models should contain both tumor cells and normal cells of the TME. Here, we describe and characterize co-culture tumor-derived organoids and cancer-associated fibroblasts (CAFs), a major component of the TME, in matrix-embedded assembloid models of esophageal adenocarcinoma (EAC). We demonstrate that the assembloid models faithfully recapitulate the differentiation status of EAC and different CAF phenotypes found in the EAC patient TME. We evaluate cell phenotypes by combining tissue-clearing techniques with whole-mount immunofluorescence and histology, providing a practical framework for the characterization of cancer assembloids.

Topics & Concepts

OrganoidEsophageal adenocarcinomaInterrogationTumor microenvironmentCancer researchAdenocarcinomaFibroblastChemistryMedicineTumor cellsBiologyCell biologyInternal medicineCancerIn vitroArchaeologyBiochemistryHistoryCancer Cells and MetastasisMathematical Biology Tumor GrowthCancer Genomics and Diagnostics
Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma | Litcius